CytoMed Therapeutics Stock Quote GDTC - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

2.64

Bid

2.35

Ask

2.65

Volume

10,138

2.52 Day's Range 2.64

1.20 52 Week Range 4.0499

Market Cap

30.466M

Previous Close

2.59

Open

2.52

Last Trade

2.4

Last Trade Time

Financial Volume

$ 26,132

VWAP

2.5776

Average Volume (3m)

228,375

Shares Outstanding

11,540,000

Dividend Yield

PE Ratio

-7.37

Earnings Per Share (EPS)

-0.36

Revenue

518k

Net Profit

-4.13M

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies into creating novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing C... CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies into creating novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.cytomed.sg.

Headquarters

Singapore, Sgp

Founded

CytoMed Therapeutics Ltd is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker GDTC. The last closing price for CytoMed Therapeutics was $2.59. Over the last year, CytoMed Therapeutics shares have traded in a share price range of $ 1.20 to $ 4.0499.

CytoMed Therapeutics currently has 11,540,000 shares outstanding. The market capitalization of CytoMed Therapeutics is $29.89 million. CytoMed Therapeutics has a price to earnings ratio (PE ratio) of -7.37.

Form S-8 - Securities to be offered to employees in employee benefit plans

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

CytoMed Therapeutics signs Business & Research Collaboration Agreement with India’s SunAct Cancer Institute Private Limited to advance use of allogeneic off-the-shelf Gamma Delta T Cells for treatment of solid cancers in a proposed Phase 2 clinical trial

SINGAPORE, Jan. 06, 2025 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based clinical stage biopharmaceutical company focused on...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Update on Clinical Milestone - CytoMed Therapeutics Announces First Patient Dosed in its First-in-Human Phase I Clinical Trial of Allogeneic CAR-Gamma Delta T Cell Therapy in Patients with Advanced Solid Tumours or Haematological Malignancies

SINGAPORE, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Further to an announcement on October 7, 2024, CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based...

Form 144 - Report of proposed sale of securities

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

CytoMed Therapeutics’ first-in-human Phase I ANGELICA clinical trial using its patented donor allogeneic chimeric antigen receptor T cell (CAR-T cell) against blood and solid tumors received co-funding support from the NMRC Clinical Trial Grant

SINGAPORE, Oct. 07, 2024 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or the “Company”), a Singapore-based biopharmaceutical company focused on harnessing its...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.17	6.88259109312	2.47	2.71	2.32	16650	2.54745138	CS
4	-0.86	-24.5714285714	3.5	4.0499	2.12	688674	3.35689782	CS
12	0.11	4.34782608696	2.53	4.0499	1.8302	228375	3.3266755	CS
26	0.85	47.4860335196	1.79	4.0499	1.2	106328	3.25852506	CS
52	-0.86	-24.5714285714	3.5	4.0499	1.2	76536	2.98115691	CS
156	-1.36	-34	4	9.25	1.2	125214	4.24006089	CS
260	-1.36	-34	4	9.25	1.2	125214	4.24006089	CS

GDTC - Frequently Asked Questions (FAQ)

What is the current CytoMed Therapeutics share price?

The current share price of CytoMed Therapeutics is $ 2.64

How many CytoMed Therapeutics shares are in issue?

CytoMed Therapeutics has 11,540,000 shares in issue

What is the market cap of CytoMed Therapeutics?

The market capitalisation of CytoMed Therapeutics is USD 29.89M

What is the 1 year trading range for CytoMed Therapeutics share price?

CytoMed Therapeutics has traded in the range of $ 1.20 to $ 4.0499 during the past year

What is the PE ratio of CytoMed Therapeutics?

The price to earnings ratio of CytoMed Therapeutics is -7.37

What is the cash to sales ratio of CytoMed Therapeutics?

The cash to sales ratio of CytoMed Therapeutics is 58.8

What is the reporting currency for CytoMed Therapeutics?

CytoMed Therapeutics reports financial results in SGD

What is the latest annual turnover for CytoMed Therapeutics?

The latest annual turnover of CytoMed Therapeutics is SGD 518k

What is the latest annual profit for CytoMed Therapeutics?

The latest annual profit of CytoMed Therapeutics is SGD -4.13M

What is the registered address of CytoMed Therapeutics?

The registered address for CytoMed Therapeutics is #08-22 ONE COMMONWEALTH, 1 COMMONWEALTH LANE, SINGAPORE, 149544

What is the CytoMed Therapeutics website address?

The website address for CytoMed Therapeutics is www.cytomed.sg.

Which industry sector does CytoMed Therapeutics operate in?

CytoMed Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
TCTMTCTM Kids IT Education Inc	$ 0.764 (321.87%)	731.1M
REBNReborn Coffee Inc	$ 3.31 (63.05%)	55.54M
FCUVFocus Universal Inc	$ 5.87 (56.62%)	1.73M
SOPASociety Pass Inc	$ 1.54 (56.50%)	13.87M
CYCNCyclerion Therapeutics Inc	$ 3.92 (54.33%)	82.57M
ENVBEnveric Biosciences Inc	$ 2.0899 (-46.41%)	1.57M
NIVFNewGenIvf Group Ltd	$ 0.1489 (-42.51%)	14.8M
GLSTGlobal Star Acquisition Inc	$ 8.83 (-39.10%)	23.89k
PRPHProPhase Labs Inc	$ 0.2633 (-38.02%)	872.46k
SPGCSacks Parente Golf Inc	$ 0.5601 (-37.86%)	7.27M
TCTMTCTM Kids IT Education Inc	$ 0.764 (321.87%)	729.72M
NVDANVIDIA Corporation	$ 120.07 (-3.67%)	388.54M
RIMEAlgorhythm Holdings Inc	$ 0.02565 (5.12%)	338.75M
BHATBlue Hat Interactive Entertainment Technology	$ 0.0355 (-11.25%)	236.29M
CLEUChina Liberal Education Holdings Ltd	$ 0.1938 (30.77%)	234.8M